Selective COX-2 inhibitor reported at AACR meeting to possess antiangiogenic and antitumor activity April 14, 2000
AACR annual meeting chosen by ProIX as forum for presentation of novel class of redox regulators April 14, 2000
Preclinical results for Avax's AC Vaccine technology in breast cancer presented at AACR April 14, 2000
RSS